# REVIEW — Product Vision Alignment

## Review — Product Vision Alignment
Gate: R1
Spec compliance: PASS
Task quality: PASS
Layer 1 (Plan alignment): PASS
Layer 2 (System integrity): PASS
Layer 3 (Production readiness): PASS
Findings: 2 Minor
Evidence reused: VALIDATION.md (PASS receipt)
Checks rerun: multiple greps + `git diff`/`git status` boundary verification — independent confirmation of the validation receipt's revision/scope basis (input files unchanged since validation)
Decision: PASS

## Scope reviewed

Workstream `dispatch/workstreams/product-vision-alignment/` on branch `feature/product-vision-alignment`. Read PLAN.md, EXPLORATION.md, ARCHITECTURE.md (blueprint), READY.md, TASK-1.md, VALIDATION.md, and the three changed context files: `context/product/vision.md`, `context/product/product-principles.md`, `context/architecture/architecture.md`. Independently verified the git diff and scope boundary. No edits performed.

## Layer 1 — Plan alignment (PASS)

All four PLAN acceptance criteria are met.

- **One authoritative home per decision.** `vision.md` owns the canonical lifecycle and the proprietary/licensed/local-first/customer-controlled direction; `product-principles.md` references the lifecycle via a relative link (`[Build → Experiment → PAPER → LIVE → Monitor → Improve](vision.md)`); `architecture.md` references it via `[Vision](../product/vision.md)` and restates neither lifecycle phrase. Verified the full canonical lifecycle string appears in full only in `vision.md` (lines 5, 37) and by link in `product-principles.md:5`. No duplicated long-form vision.
- **Lifecycle, direction, operation, Strategy principles, and licensing boundary all clear.** `vision.md:5` states direction declaratively with no license types, pricing, telemetry, hosting, distribution, or enforcement design. The Safety-Independent Licensing Boundary principle (`product-principles.md:59-61`) is declarative and explicitly "future boundary only; it creates no current implementation task." Existing Strategy principles (Strategy First, Same Methodology Everywhere, Immutable Evidence, Centralized Risk, Completed Data Only) preserved verbatim.
- **No scope expansion.** Independent `git diff --stat` confirms exactly `3 files changed, 9 insertions(+), 5 deletions(-)` confined to the three prescribed files. `context/roadmap/roadmap.md` and all `context/features/*` unchanged (`git status --porcelain` empty). The `context/architecture/database.md` working-tree modification predates this workstream (Phase 5), confirmed out of scope. No application code, schema, dependency, or configuration attributable to this task.
- **No contradictory statement.** Independently grepped `context/` for the legacy lifecycle (`build → test`, `test → deploy`, `Test → Deploy`) — no remaining matches. No `Backtest|BacktestRun|PaperBot|LiveBot|StrategyInstance` in `context/product` or `context/architecture/architecture.md`. Canonical `StrategyVersion`/`Experiment`/`PAPER`/`LIVE`/`Deployment`/`Risk` capitalization and meanings intact.

## Layer 2 — System integrity (PASS)

- **User request vs. one-authority rule.** The blueprint's "define once, link elsewhere" pattern is honored; architecture is not a second lifecycle authority. The architectural consequence "The same StrategyVersion should move through Experiment → PAPER → LIVE without changing its trading methodology" is retained at `architecture.md:5`.
- **No contradiction with repo-wide boundaries.** The new "proprietary, licensed, local-first" direction was checked beyond `context/`: README.md and AGENTS.md contain no open-source/licensing claim that could conflict (only an unrelated "installs" string match). `design.md:5` "not a generic SaaS dashboard" is consistent. "Local-first" is correctly framed as customer-controlled (not offline-only), with broker/market-data remaining external dependencies (`vision.md:5`), preserving OANDA/broker-authority boundaries.
- **Safety invariants intact.** The new licensing principle explicitly preserves correctness, fail-closed behavior, broker-hosted protection, reconciliation, exposure visibility, and safe risk-reducing actions, and cannot be read to weaken them. AGENTS.md invariants remain unconditional. No commercial/SaaS/multi-tenancy/billing/installers/cloud/SDK infrastructure authorized.
- **Roadmap authority preserved.** `roadmap.md` untouched; deferred "multi-user SaaS" (line 67) remains compatible with single-user local-first and is restated consistently in `vision.md` line 25 Out-of-Scope.

## Layer 3 — Production readiness (PASS)

Documentation-only work; readiness assessed as correctness of content, link resolution, and auditability.

- Relative links resolve: both `context/product/vision.md` and `context/architecture/../product/vision.md` exist (same 2889-byte file).
- Markdown headings valid; terminology matches `domain-model.md`.
- **Product Vision Alignment Audit readiness:** PASS. The change set is minimal and surgical; EXPLORATION.md captured the exact before-state (current statements, material contradiction, gaps, minimal change set, cross-reference needs); the diff is confined to three files; VALIDATION.md documents each check with reusable receipts. The declarative, future-only framing of licensing/local-first keeps the state cleanly auditable without an audit having been performed (per PLAN, "no alignment audit is in scope" — respected).

## Findings

- **Minor** — `PLAN.md` ordered-tasks table contains two duplicate "Documentation review | reviewer | REVIEW.md" rows (one "in progress", one "pending"). Dispatch bookkeeping only; does not affect product content, authority, or scope. Remedy: collapse to a single row on closure.
- **Minor** — "customer-controlled"/"customer's control" wording appears in both `vision.md:5` and `vision.md:13`. Not a long-form duplication and harmless; optional consolidation on future edits.

No Critical or Important findings.

## Evidence reused

- VALIDATION.md (PASS receipt) — valid; its revision/scope basis (the three context files) and environment are unchanged since it ran. Its claims were independently re-confirmed, not blindly accepted.

## Checks rerun

- `git diff` (3 files / 9+/5-), `git status --porcelain` on `context/roadmap/` and `context/features/` — confirm scope boundary and receipt validity.
- Grep `context/` for legacy `build → test` / `test → deploy` / `Test → Deploy` — no matches.
- Grep `context/` for canonical lifecycle — hits only `vision.md` (lines 5, 37) and link in `product-principles.md:5`.
- Grep `context/product` + `architecture.md` for Backtest/Bot/StrategyInstance terms — no matches.
- Grep README.md / AGENTS.md for licensing/open-source claims — none contradict.
- Link existence via `ls` for both relative-link targets.

## Decision

PASS — R1 gate satisfied. No Critical or Important finding remains. Spec compliance and task quality both PASS. The workstream is eligible to proceed to closure (documenter completes COMPLETED.md, `/remember save`, clears ACTIVE.md per the review skill's terminal-eligibility rules). The two Minor findings are recorded for follow-up and do not block.
